Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes

Journal of Bone and Mineral Research

Volumn 25, Issue 3, 2010, Pages 661-672

  Gallois, A ^a   Lachuer, J ^a   Yvert, G ^b   Wierinckx, A ^a   Brunet, F ^a   Rabourdin Combe, C ^a   Delprat, C ^b   Jurdic, Pierre ^a   Mazzorana, M ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Dendritic cells; Osteoclasts; Osteoimmunology; Rheumatoid arthritis; Transcriptomic analyses

Indexed keywords

CELL MARKER; COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR; MEMBRANE ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELL; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MARKER GENE; MONOCYTE; NORMAL HUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; TRANSCRIPTOMICS; UPREGULATION; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; METABOLISM; OSTEOLYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, SURFACE; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MONOCYTES; OSTEOCLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77953395305     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090829     Document Type: Article

References (46)

1. Saltel F, Chabadel A, Bonnelye E, Jurdic P. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur J Cell Biol 2008;87:459-468.
2. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998;152:943-951. (Pubitemid 28173356)
3. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007;7:292-304. (Pubitemid 46480961)
4. Koga T, Inui M, Inoue K, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 2004;428:758-763. (Pubitemid 38508286)
5. Shinohara M, Koga T, Okamoto K, et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 2008;132:794-806. (Pubitemid 351312796)
6. Ochi S, Shinohara M, Sato K, et al. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci USA 2007;104:11394-11399. (Pubitemid 47175151)
7. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-2682. (Pubitemid 44833343)
8. Testa NG, Allen TD, Lajtha LG, Onions D, Jarret O. Generation of osteoclasts in vitro. J Cell Sci 1981;47:127-137.
9. Udagawa N, Takahashi N, Akatsu T, et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989;125:1805-1813. (Pubitemid 19258613)
10. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004;118:149-161. (Pubitemid 38962572)
11. Udagawa N, Takahashi N, Akatsu T, et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 1990;87:7260-7264. (Pubitemid 20325246)
12. Solari F, Flamant F, Cherel Y, Wyers M, Jurdic P. The osteoclast generation: an in vitro and in vivo study with a genetically labelled avian monocytic cell line. J Cell Sci 1996;109:1203-1213. (Pubitemid 26190474)
13. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002;99:111-120.
14. Rivollier A, Mazzorana M, Tebib J, et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 2004;104:4029-4037. (Pubitemid 39620153)
15. Speziani C, Rivollier A, Gallois A, et al. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol 2007;37:747-757. (Pubitemid 46916941)
16. Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 2008;14:81-87.
17. Alnaeeli M, Penninger JM, Teng YT. Immune interactions with CD4 + T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells. J Immunol 2006;177:3314-3326.
18. Wakkach A, Mansour A, Dacquin R, et al. Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood 2008;112:5074-5083.
19. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186:813-823. (Pubitemid 27407343)
20. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118. (Pubitemid 24091769)
21. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868. (Pubitemid 29003722)
22. Alnaeeli M, Park J, Mahamed D, Penninger JM, Teng YT. Dendritic cells at the osteo-immune interface: implications for inflammation-induced bone loss. J Bone Miner Res 2007;22:775-780. (Pubitemid 351339736)
23. Horlock C, Shakib F, Mahdavi J, Jones NS, Sewell HF, Ghaemmaghami AM. Analysis of proteomic profiles and functional properties of human peripheral blood myeloid dendritic cells. monocyte-derived dendritic cells and the dendritic cell-like KG-1 cells reveals distinct characteristics. Genome Biol. 2007;8:R30. (Pubitemid 351851059)
24. Robbins SH, Walzer T, Dembele D, et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 2008; 9:R17. (Pubitemid 351911930)
25. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
26. Crotti TN, Flannery M, Walsh NC, Fleming JD, Goldring SR, McHugh KP. NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiation. Gene 2006;372:92-102.
27. Kim K, Lee SH, Ha Kim J, Choi Y, Kim N. NFATc1 induces osteoclast fusion via upregulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 2008;22:176-185.
28. Aliprantis AO, Ueki Y, Sulyanto R, et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest 2008;118:3775-3789.
29. Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 2007;179: 7577-7584.
30. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669-692.
31. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19-30.
32. Hayman AR, Macary P, Lehner PJ, Cox TM. Tartrate-resistant acid phosphatase (Acp5): identification in diverse human tissues and dendritic cells. J Histochem Cytochem 2001;49:675-684. (Pubitemid 32553438)
33. Janckila AJ, Parthasarathy RN, Parthasarathy LK, et al. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells. J Leukoc Biol 2005;77:209-218. (Pubitemid 40315055)
34. Hayman AR, Bune AJ, Cox TM. Widespread expression of tartrate-resistant acid phosphatase (Acp5) in the mouse embryo. J Anat 2000;196:433-441. (Pubitemid 30333063)
35. Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM. Osteoclastic tartrate-resistant acid phosphatase (Acp5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem 2000;48:219-228. (Pubitemid 30127059)
36. Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NF-κB. J Biol Chem 2002;277:21971-21982. (Pubitemid 34952352)
37. Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 2005; 115:3418-3427. (Pubitemid 43121830)
38. Seshasayee D, Wang H, Lee WP, et al. A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response. J Biol Chem 2004;279:30202-30209. (Pubitemid 38937945)
39. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 2007; 82:710-720. (Pubitemid 47367163)
40. Lewis DB, Liggitt HD, Effmann EL, et al. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 1993;90:11618-11622.
41. Park BK, Zhang H, Zeng Q, et al. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007;13:62-69. (Pubitemid 46067387)
42. Miyamoto T, Ohneda O, Arai F, et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 2001;98:2544-2554. (Pubitemid 32620029)
43. Moreno JL, Kaczmarek M, Keegan AD, Tondravi M. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 2003;102:1078-1086. (Pubitemid 36917809)
44. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-5341. (Pubitemid 34496002)
45. Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 1999;66:286-292. (Pubitemid 29379170)
46. Page G, Miossec P. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum 2005;52:2307-2312. (Pubitemid 41117414)